202 related articles for article (PubMed ID: 15051478)
1. Latanoprost-induced pigmentation in human iridial melanocytes is fibroblast dependent.
Smith-Thomas L; Moustafa M; Spada CS; Shi L; Dawson RA; Wagner M; Balafa C; Kedzie KM; Reagan JW; Krauss AH; Woodward DF; MacNeil S
Exp Eye Res; 2004 May; 78(5):973-85. PubMed ID: 15051478
[TBL] [Abstract][Full Text] [Related]
2. Increased pigmentation of iridial melanocytes in primates induced by a prostaglandin analogue.
Lindquist NG; Larsson BS; Stjernschantz J
Exp Eye Res; 1999 Oct; 69(4):431-6. PubMed ID: 10504276
[TBL] [Abstract][Full Text] [Related]
3. Cellular and hormonal regulation of pigmentation in human ocular melanocytes.
Smith-Thomas LC; Moustafa M; Dawson RA; Wagner M; Balafa C; Haycock JW; Krauss AH; Woodward DF; MacNeil S
Pigment Cell Res; 2001 Aug; 14(4):298-309. PubMed ID: 11549114
[TBL] [Abstract][Full Text] [Related]
4. Dopa oxidase activity in the hair, skin and ocular melanocytes is increased in the presence of stressed fibroblasts.
Balafa C; Smith-Thomas L; Phillips J; Moustafa M; George E; Blount M; Nicol S; Westgate G; MacNeil S
Exp Dermatol; 2005 May; 14(5):363-72. PubMed ID: 15854130
[TBL] [Abstract][Full Text] [Related]
5. Latanoprost and pigmentation.
Grierson I; Jonsson M; Cracknell K
Jpn J Ophthalmol; 2004; 48(6):602-12. PubMed ID: 15592791
[TBL] [Abstract][Full Text] [Related]
6. Latanoprost-induced increase of tyrosinase transcription in iridial melanocytes.
Stjernschantz J; Ocklind A; Wentzel P; Lake S; Hu DN
Acta Ophthalmol Scand; 2000 Dec; 78(6):618-22. PubMed ID: 11167218
[TBL] [Abstract][Full Text] [Related]
7. Production of prostaglandin e(2) by iridial melanocytes exposed to latanoprost acid, a prostaglandin F(2 alpha) analogue.
Bergh K; Wentzel P; Stjernschantz J
J Ocul Pharmacol Ther; 2002 Oct; 18(5):391-400. PubMed ID: 12419090
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin induces the expression of matrix metalloproteinase-1 in ciliary melanocytes.
Wang NL; Lu QJ; Li JH; Wang L
Chin Med J (Engl); 2008 Jul; 121(13):1173-6. PubMed ID: 18710634
[TBL] [Abstract][Full Text] [Related]
9. alpha-Methyl-p-tyrosine inhibits latanoprost-induced melanogenesis in vitro.
Drago F; Marino A; La Manna C
Exp Eye Res; 1999 Jan; 68(1):85-90. PubMed ID: 9986745
[TBL] [Abstract][Full Text] [Related]
10. Mechanism and clinical significance of prostaglandin-induced iris pigmentation.
Stjernschantz JW; Albert DM; Hu DN; Drago F; Wistrand PJ
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S162-75. PubMed ID: 12204714
[TBL] [Abstract][Full Text] [Related]
11. Uveal melanocytes do not respond to or express receptors for alpha-melanocyte-stimulating hormone.
Li L; Hu DN; Zhao H; McCormick SA; Nordlund JJ; Boissy RE
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4507-12. PubMed ID: 17003446
[TBL] [Abstract][Full Text] [Related]
12. Transcription of prostanoid receptor genes and cyclooxygenase enzyme genes in cultivated human iridial melanocytes from eyes of different colours.
Wentzel P; Bergh K; Wallin O; Niemelä P; Stjernschantz J
Pigment Cell Res; 2003 Feb; 16(1):43-9. PubMed ID: 12519124
[TBL] [Abstract][Full Text] [Related]
13. Intracellular signaling in human iridial fibroblasts and iridial melanocytes in response to prostaglandins, endothelin, isoproterenol, and other pharmacological agents.
Sharif NA; Crider JY
Curr Eye Res; 2011 Apr; 36(4):310-20. PubMed ID: 21405953
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug.
Takagi Y; Nakajima T; Shimazaki A; Kageyama M; Matsugi T; Matsumura Y; Gabelt BT; Kaufman PL; Hara H
Exp Eye Res; 2004 Apr; 78(4):767-76. PubMed ID: 15037111
[TBL] [Abstract][Full Text] [Related]
15. Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma lines.
Dutkiewicz R; Albert DM; Levin LA
Exp Eye Res; 2000 May; 70(5):563-9. PubMed ID: 10870514
[TBL] [Abstract][Full Text] [Related]
16. Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes.
Chou SY; Chou CK; Kuang TM; Hsu WM
Eye (Lond); 2005 Jul; 19(7):784-7. PubMed ID: 15359238
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost.
Chiba T; Kashiwagi K; Ishijima K; Furuichi M; Kogure S; Abe K; Chiba N; Tsukahara S
Jpn J Ophthalmol; 2004; 48(2):141-7. PubMed ID: 15060793
[TBL] [Abstract][Full Text] [Related]
18. Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys.
Prota G; Vincensi MR; Napolitano A; Selen G; Stjernschantz J
Pigment Cell Res; 2000 Jun; 13(3):147-50. PubMed ID: 10885672
[TBL] [Abstract][Full Text] [Related]
19. Effects of prostaglandin F2alpha and latanoprost on phosphoinositide turnover, myosin light chain phosphorylation and contraction in cat iris sphincter.
Ansari HR; Davis AM; Kaddour-Djebbar I; Abdel-Latif AA
J Ocul Pharmacol Ther; 2003 Jun; 19(3):217-31. PubMed ID: 12828840
[TBL] [Abstract][Full Text] [Related]
20. Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein.
Errasti AE; del-Rey G; Cesio CE; Souza G; Nowak W; Pelorosso FG; Daray FM; Rothlin RP
Eur J Pharmacol; 2009 May; 610(1-3):68-74. PubMed ID: 19289115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
